Comparison of Penile Size and Erectile Function after High-intensity Focused Ultrasound and Targeted Cryoablation for Localized Prostate Cancer: A Prospective Pilot Study

Journal of Sexual Medicine

Volumn 7, Issue 9, 2010, Pages 3135-3142

  Li, Liao Yuan ^a   Lin, Zhe ^a   Yang, Ming ^a   Gao, Xin ^a   Xia, Tao Lin ^a   Ding, Tao ^b  

^a SUN YAT SEN UNIVERSITY   (China)

^b UNIVERSITY OF SOUTH CHINA   (China)

Author keywords

Cryoablation; Erectile dysfunction; High intensity focused ultrasound; Prostate cancer

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; SILDENAFIL;

ADULT; ARTICLE; CLINICAL TRIAL; COLOR ULTRASOUND FLOWMETRY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRYOABLATION; ERECTILE DYSFUNCTION; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; INTERMETHOD COMPARISON; INTERNATIONAL INDEX OF ERECTILE FUNCTION; MAJOR CLINICAL STUDY; MALE; ORGAN SIZE; OUTCOME ASSESSMENT; PENIS ERECTION; PENIS SIZE; PILOT STUDY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; QUALITY OF LIFE; VACUUM;

EID: 77956273210     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2010.01751.x     Document Type: Article

References (39)

1. Ganzer R, Rogenhofer S, Walter B, Lunz JC, Schostak M, Wieland WF, Blana A. PSA nadir is a significant predictor of treatment failure after high-intensity focussed ultrasound (HIFU) treatment of localised prostate cancer. Eur Urol 2008, 53:547-53.
2. Han KR, Belldegrun AS. Third generation cryosurgery for primary and recurrent prostate cancer. BJU Int 2004, 93:14-8.
3. Chartier-Kastler E, Amar E, Chevallier D, Montaigne O, Coulange C, Joubert JM, Giuliano F. Does management of erectile dysfunction after radical prostatectomy meet patients' expectations? Results of a national survey (REPAIR) by the French Urological Association. J Sex Med 2008, 5:693-704.
4. Asterling S, Greene DR. Prospective evaluation of sexual function in patients receiving cryosurgery as a primary radical treatment for localized prostate cancer. BJU Int 2009, 103:788-92.
5. Tal R, Alphs HH, Krebs P, Nelson CJ, Mulhall JP. Erectile function recovery rate after radical prostatectomy: A meta-analysis. J Sex Med 2009, 6:2538-46.
6. Briganti A, Fabbri F, Salonia A, Gallina A, Chun FK, Dehò F, Zanni G, Suardi N, Karakiewicz PI, Rigatti P, Montorsi F. Preserved postoperative penile size correlates well with maintained erectile function after bilateral nerve-sparing radical retropubic prostatectomy. Eur Urol 2007, 52:702-7.
7. Munding MD, Wessels HB, Dalkin BL. Pilot study of changes in stretched penile length 3 months after radical retropubic prostatectomy. Urology 2001, 58:567-9.
8. Savoie M, Kim SS, Soloway MS. A prospective study measuring penile length in men treated with radical prostatectomy for prostate cancer. J Urol 2003, 169:1462-4.
9. Li LY, Yang M, Gao X, Zhang HB, Li JF, Xu WF, Lin Z, Zhou XL. Prospective comparison of five mediators of the systemic response after high-intensity focused ultrasound and targeted cryoablation for localized prostate cancer. BJU Int 2009, 104:1063-7.
10. Virag R, Frydman D, Legman M, Virag H. Intracavernous injection of papaverine as a diagnostic and therapeutic method in erectile failure. Angiology 1984, 35:79-87.
11. Poissonnier L, Chapelon JY, Rouvière O, Curiel L, Bouvier R, Martin X, Dubernard JM, Gelet A. Control of prostate cancer by transrectal HIFU in 227 patients. Eur Urol 2007, 51:381-7.
12. Merrick GS, Wallner KE, Butler WM. Prostate cryotherapy: More questions than answers. Urology 2005, 66:9-15.
13. Chaussy C, Thüroff S. Results and side effects of high-intensity focused ultrasound in localized prostate cancer. J Endourol 2001, 15:437-40.
14. Rebillard X, Soulié M, Chartier-Kastler E, Davin JL, Mignard JP, Moreau JL, Coulange C. High-intensity focused ultrasound in prostate cancer; a systematic literature review of the French Association of Urology. BJU Int 2008, 101:1205-13. Association Francaise d'Urologie
15. Bahn DK, Lee F, Badalament R, Kumar A, Greski J, Chernick M. Targeted cryoablation of the prostate: 7-year outcomes in the primary treatment of prostate cancer. Urology 2002, 60(2):3-11. suppl
16. Long JP, Bahn D, Lee F, Shinohara K, Chinn DO, Macaluso JN. Five-year retrospective, multi-institutional pooled analysis of cancer-related outcomes after cryosurgical ablation of the prostate. Urology 2001, 57:518-23.
17. Burnett AL, Aus G, Canby-Hagino ED, Cookson MS, D'Amico AV, Dmochowski RR, Eton DT, Forman JD, Goldenberg SL, Hernandez J, Higano CS, Kraus S, Liebert M, Moul JW, Tangen C, Thrasher JB, Thompson I. Erectile function outcome reporting after clinically localized prostate cancer treatment. J Urol 2007, 178:597-601.
18. Mulhall JP. Defining and reporting erectile function outcomes after radical prostatectomy: Challenges and misconceptions. J Urol 2009, 181:462-71.
19. Robinson JW, Donnelly BJ, Saliken JC, Weber BA, Ernst S, Rewcastle JC. Quality of life and sexuality of men with prostate cancer 3 years after cryosurgery. Urology 2002, 60:12-8.
20. Häcker A, Köhrmann KU, Back W, Kraut O, Marlinghaus E, Alken P, Michel MS. Extracorporeal application of high-intensity focused ultrasound for prostatic tissue ablation. BJU Int 2005, 96:71-6.
21. Ellis DS, Manny TB, Rewcastle JC. Cryoablation as primary treatment for localized prostate cancer followed by penile rehabilitation. Urology 2007, 69:306-10.
22. McCullough AR, Levine LA, Padma-Nathan H. Return of nocturnal erections and erectile function after bilateral nerve-sparing radical prostatectomy in men treated nightly with sildenafil citrate: Subanalysis of a longitudinal randomized double-blind placebo-controlled trial. J Sex Med 2008, 5:476-84.
23. Köhler TS, Pedro R, Hendlin K, Utz W, Ugarte R, Reddy P, Makhlouf A, Ryndin I, Canales BK, Weiland D, Nakib N, Ramani A, Anderson JK, Monga M. A pilot study on the early use of the vacuum erection device after radical retropubic prostatectomy. BJU Int 2007, 100:858-62.
24. Zagaja GP, Mhoon DA, Aikens JE, Brendler CB. Sildenafil in the treatment of erectile dysfunction after radical prostatectomy. Urology 2000, 56:631-4.
25. Ohebshalom M, Parker M, Waters B, Flanagan R, Mulhall JP. Erectile haemodynamic status after radical prostatectomy correlates with erectile functional outcome. BJU Int 2008, 102:592-6.
26. Mulhall JP, Barnas J, Aviv N, Anderson M, Parker M. Sildenafil citrate response correlates with the nature and the severity of penile vascular insufficiency. J Sex Med 2005, 2:104-8.
27. Mulhall JP, Slovick R, Hotaling J, Aviv N, Valenzuela R, Waters WB, Flanigan RC. Erectile dysfunction after radical prostatectomy: Hemodynamic profiles and their correlation with the recovery of erectile function. J Urol 2002, 167:1371-5.
28. Aversa A, Sarteschi LM. The role of penile color-duplex ultrasound for the evaluation of erectile dysfunction. J Sex Med 2007, 4:1437-47.
29. Kaiser DR, Billups K, Mason C, Wetterling R, Lundberg JL, Bank AJ. Impaired brachial artery endothelium-dependent and -independent vasodilation in men with erectile dysfunction and no other clinical cardiovascular disease. J Am Coll Cardiol 2004, 43:179-84.
30. El-Sakka A, Hassan MU, Bakircioglu ME, Pillarisetty RJ, Dahiya R, Lue TF. Possible molecular mechanisms of cryoablation-induced impotence in a rat model. Urology 1998, 52:1144-50.
31. Mulhall JP. Penile length changes after radical prostatectomy. BJU Int 2005, 96:472-4.
32. Schwartz EJ, Wong P, Graydon J. Sildenafil preserves intracorporeal smooth muscle after radical retropubic prostatectomy. J Urol 2004, 171:771-4.
33. Muto S, Yoshii T, Saito K, Kamiyama Y, Ide H, Horie S. Focal therapy with high-intensity-focused ultrasound in the treatment of localized prostate cancer. Jpn J Clin Oncol 2008, 38:192-9.
34. Morales A, Lunenfeld B. International Society for the Study of the Aging male. Investigation, treatment and monitoring of late-onset hypogonadism in males. Official recommendations of ISSAM. International Society for the Study of the Aging Male. Aging Male 2002, 5:74-86.
35. Agarwal PK, Oefelein MG. Testosterone replacement therapy after primary treatment for prostate cancer. J Urol 2005, 173:533-6.
36. Pickles T, Graham P. Members of the British Columbia cancer agency prostate cohort outcomes initiative. What happens to testosterone after prostate radiation monotherapy and does it matter? J Urol 2002, 167:2448-52.
37. Mulhall JP, Abdel-Moneim A, Abobakr R, Goldstein I. Improving the accuracy of vascular testing in impotent men: Correcting hemodynamic alterations using a vasoactive medication re-dosing schedule. J Urol 2001, 166:923-6.
38. Montorsi F, Guazzoni G, Barbieri L, Ferini-Strambi L, Iannaccone S, Calori G, Nava L, Rigatti P, Pizzini G, Miani A. Genital plus audiovisual sexual stimulation following intracavernous vasoactive injection versus re-dosing for erectile dysfunction-results of a prospective study. J Urol 1998, 159:113-5.
39. Bhojani N, Perrotte P, Jeldres C, Suardi N, Hutterer G, Shariat SF, Karakiewicz PI. The effect of comorbidities and socioeconomic status on sexual and urinary function in men undergoing prostate cancer screening. J Sex Med 2008, 5:668-76.